1. Home
  2. Live Updates
  3. Device agency

Live Breaking News & Updates on Device agency

Stay informed with the latest breaking news from Device agency on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Device agency and stay connected to the pulse of your community

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®

United-states , Niigata , Japan , Japanese , Robert-mulroy , Partner-therapeutics-inc , Division-of-pioneering-advanced-therapeutics , Nobelpharma-co , Device-agency , Innovation-of-niigata-university-medical-dental-hospital , Japanese-pharmaceuticals , Niigata-university

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Japan , Niigata , Japanese , Robert-mulroy , Nobelpharma-co , Innovation-of-niigata-university-medical-dental-hospital , Device-agency , Japanese-pharmaceuticals , Division-of-pioneering-advanced-therapeutics , Tanner-pharma-group , Niigata-university

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...

Niigata , Japan , United-states , Japanese , Robert-mulroy , Device-agency , Innovation-of-niigata-university-medical-dental-hospital , Japanese-pharmaceuticals , Tanner-pharma-group , Division-of-pioneering-advanced-therapeutics , Nobelpharma-co , Niigata-university

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Niigata , Japan , United-states , Japanese , Robert-mulroy , Tanner-pharma-group , Niigata-university , Division-of-pioneering-advanced-therapeutics , Prnewswire-partner-therapeutics-inc , Nobelpharma-co , Japanese-pharmaceuticals , Device-agency

BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript

BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.

United-states , Minnesota , Japan , David-mcclung , Peter-altman , Brent-pearson , Joe-smith , Miranda-peto , Largest-airport-companies , Sam-club , Device-agency , Biocardia-inc

BioCardia : Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results -March 27, 2024 at 01:30 pm EDT

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results


March 27, 2024


BioCardia®, Inc. [Nasdaq: BCDA], a developer of...

Japan , United-states , Maryland , California , Japanese , Finkelstein-schoenfeld , Peter-altman , Device-agency , Medicaid-services , Nasdaq , Exchange-commission-on , Biocardia-inc

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Maryland , United-states , California , Japanese , David-mcclung , Miranda-peto , Finkelstein-schoenfeld , Peter-altman , Nasdaq , Company-annual-report-on-form , Exchange-commission

Biocardia Reports Fourth Quarter And Full Year 2023 Business Highlights And Financial Results

Biocardia Reports Fourth Quarter And Full Year 2023 Business Highlights And Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Japan , Maryland , United-states , California , Japanese , Peter-altman , Miranda-peto , Finkelstein-schoenfeld , David-mcclung , Device-agency , Exchange-commission-on , Medicaid-services

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , California , Maryland , Japanese , Peter-altman , Miranda-peto , Finkelstein-schoenfeld , David-mcclung , Nasdaq , Exchange-commission , Medicaid-services

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.

Japan , France , Italy , Germany , United-states , Spain , America , Japanese , Tim-lugo , Gavin-clark-gartner , Christine-wilson , Alec-stranahan